<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Programmed <z:hpo ids='HP_0011420'>death</z:hpo>-1 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1) is expressed by germinal center-associated helper T-cells and acts as a negative regulator of the immune system </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 is encountered on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells of angioimmunoblastic T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and is a postulated diagnostic marker in <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (<z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Recent data suggest prognostic importance of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 in follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) </plain></SENT>
<SENT sid="3" pm="."><plain>We assessed the diagnostic potential and the prognostic importance of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 in B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Distribution of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1+ lymphocytes in B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> was studied on 403 cases </plain></SENT>
<SENT sid="5" pm="."><plain>Correlation with known biologic and clinical key data was performed </plain></SENT>
<SENT sid="6" pm="."><plain>Prognostic cut-off scores were determined by receiver operating curve analysis </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1+ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-infiltrating lymphocytes were numerous in extranodal marginal zone <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and FL </plain></SENT>
<SENT sid="8" pm="."><plain>Their amount decreased from FL grade 1 to grade 3 and to FL with transformation to diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>An increased amount of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 tumor-infiltrating lymphocytes above the prognostic cut-off score (&gt; 2.8%) was a positive prognostic factor of disease-specific survival (DSS) in FL-patients </plain></SENT>
<SENT sid="10" pm="."><plain>Five percent of the studied 66 CLL/SLL cases showed unequivocal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 positivity of neoplastic cells </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Increased number of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1+ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-infiltrating lymphocytes is associated with significantly improved DSS in FL and may be useful to predict its <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> clinical behavior </plain></SENT>
<SENT sid="12" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-1 has probably limited diagnostic value for primary histopathological <z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e> diagnostics </plain></SENT>
</text></document>